Automated extrusion-based dispensing: Personalized dosing and quality control of clopidogrel tablets for pediatric care
European Journal of Pharmaceutical Sciences · 2025-01 · 204 · 106967
DOI: 10.1016/j.ejps.2024.106967 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutical Sciences, 2025-01. Verfasst von Farnaz Shokraneh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Sciences Laboratory, Science and Engineering, Åbo Akademi University, BioCity, Tykistökatu 6A, Turku FI-20520, Finland; CurifyLabs Oy,…. Hauptthemen laut MEDLINE: Clopidogrel, Tablets, Drug Compounding, Platelet Aggregation Inhibitors. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The exploration of three-dimensional (3D) printing inspired technologies in pharmaceutical compounding reveals a promising frontier in personalized medicine manufacture. This study focuses on the development of clopidogrel bisulphate tablets, with doses ranging from 2 mg to 20 mg per tablet, suitable for pediatric use. The study explored a semi-solid extrusion-based deposition technology already being used in compounding pharmacies across several European locations. The investigation explored various properties of two formulations of 1 % and 2 % clopidogrel gel tablets, with a specific focus on mass variation, drug content uniformity, in vitro drug release profiles, disintegration time, and stability. The mean weights of the smallest printed 200 mg tablets with 1 % and 2 % clopidogrel concentrations were 199.1 ± 4.6 mg and 201.0 ± 3.2 mg, respectively. For the largest printed 500 mg tablets with 1 % and 2 % concentrations, the mean weights were 499.3 ± 7.7 mg and 501.7 ± 6.5 mg, respectively. The mean clopidogrel content uniformity for 1 % clopidogrel 200 mg and 500 mg tablets were 102.0 ± 1.8 %and 96.6 ± 2.6 %, respectively, and for 2 % clopidogrel 200 mg and 500 mg were 102.6 ± 3.9 % and 101.2 ± 1.6 %, respectively, well within the acceptable acceptance value (AV) range of 3 to 12. Both 1 % and 2 % formulations of clopidogrel tablets exhibited rapid drug release, meeting the USP pharmacopeial target of 85 % release in 15 min. All tablet sizes formulated at 1 % and 2 % concentrations met specified disintegration specifications. The stability assessment over three months revealed consistent pH values and assay results within target specifications for both clopidogrel formulations (93.5 % for 1 % formulation and 93.6 % for 2 % formulation). At three months, X-ray Diffraction (XRD) and Fourier Transform Infrared Spectroscopy (FTIR) results demonstrated stability in clopidogrel tablets. In conclusion, a comprehensive evaluation of our developed clopidogrel tablets demonstrate their suitability for clinical use in an extemporaneous setting using the presented semi-solid extrusion-based automation technology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Sciences Laboratory, Science and Engineering, Åbo Akademi University, BioCity, Tykistökatu 6A, Turku FI-20520, Finland; CurifyLabs Oy, Salmisaarenaukio 1, Helsinki FI-00180, Finland. Electronic address: f…
- Pharmaceutical Sciences Laboratory, Science and Engineering, Åbo Akademi University, BioCity, Tykistökatu 6A, Turku FI-20520, Finland.
- Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Kiinamyllynkatu 10, Turku FI-20520, Finland; Unit of Clinical Pharmacology, Turku University Hospital, Kiinamyllynkatu 10, Turku 20…
- Department of Geology, University of Tartu, Institute of Ecology and Earth Sciences, Ravila 14a, Tartu 50411, Estonia.
- Faculty of Medicine, Tartu University, Institute of Pharmacy, Nooruse 1, Tartu EE-50411, Estonia.
- Pharmaceutical Sciences Laboratory, Science and Engineering, Åbo Akademi University, BioCity, Tykistökatu 6A, Turku FI-20520, Finland; CurifyLabs Oy, Salmisaarenaukio 1, Helsinki FI-00180, Finland.
Zitieren
APA
Shokraneh, F., Filppula, A. M., Tornio, A., Aruväli, J., Paaver, U., & Topelius, N. S. (2025). Automated extrusion-based dispensing: Personalized dosing and quality control of clopidogrel tablets for pediatric care. European Journal of Pharmaceutical Sciences, 204, 106967. https://doi.org/10.1016/j.ejps.2024.106967
Vancouver
Shokraneh F, Filppula AM, Tornio A, Aruväli J, Paaver U, Topelius NS. Automated extrusion-based dispensing: Personalized dosing and quality control of clopidogrel tablets for pediatric care. European Journal of Pharmaceutical Sciences. 2025;204:106967. doi:10.1016/j.ejps.2024.106967
BibTeX
@article{Shokraneh2025,
author = {Shokraneh, Farnaz and Filppula, Anne M and Tornio, Aleksi and Aruväli, Jaan and Paaver, Urve and Topelius, Niklas Sandler},
title = {Automated extrusion-based dispensing: Personalized dosing and quality control of clopidogrel tablets for pediatric care},
journal = {European Journal of Pharmaceutical Sciences},
year = {2025},
volume = {204},
pages = {106967},
doi = {10.1016/j.ejps.2024.106967}
}
EUVIMED